Glyclopyramide

Glyclopyramide (INN, marketed under the tradename Deamelin-S) is a sulfonylurea drug used in the treatment of diabetes. It has been marketed in Japan since 1965.

Glyclopyramide

Clinical data
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 4-chloro-N-[(pyrrolidin-1-ylamino)carbonyl]benzenesulfonamide
CAS Number	631-27-6 N
PubChem CID	71793
ChemSpider	64820 N
UNII	KE474IKG1W
KEGG	D01799 Y
ChEMBL	ChEMBL2105083 N
CompTox Dashboard (EPA)	DTXSID2048822
Chemical and physical data
Formula	C11H14ClN3O3S
Molar mass	303.76 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CCN(C1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)Cl
InChI InChI=1S/C11H14ClN3O3S/c12-9-3-5-10(6-4-9)19(17,18)14-11(16)13-15-7-1-2-8-15/h3-6H,1-2,7-8H2,(H2,13,14,16) N Key:HNSCCNJWTJUGNQ-UHFFFAOYSA-N N
NY (what is this?)  (verify)

It is classified as second generation.^[1]